Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Dental ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Psychological factors associated with development of TMD: the OPPERA prospective cohort study.J Pain. 2013; 14: T75-T90
- Sleep and orofacial pain.Dent Clin North Am. 2018; 62: 629-656
- Bruxism defined and graded: an international consensus.J Oral Rehabil. 2013; 40: 2-4
- Efficacy of botulinum toxin in the treatment of bruxism: systematic review.Med Oral Patol Oral Cir Bucal. 2019; 24: e416-e424
- The role of magnesium in neurological disorders.Nutrients. 2018; 10: 730
- Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society.Neurology. 2012; 78: 1346-1353
- EFNS guideline on the drug treatment of migraine--revised report of an EFNS task force.Eur J Neurol. 2009; 16: 968-981
- Migraine and tension-type headache: diagnosis and treatment.Med Clin North Am. 2019; 103: 215-233
- Nortriptyline compared to amitriptyline for the treatment of persistent masticatory myofascial pain.J Oral Facial Pain Headache. 2019; 33: 7-13
- Medical progress: temporomandibular disorders.N Engl J Med. 2008; 359: 2693-2705
- Epidemiology of temporomandibular disorders: implications for the investigation of etiologic factors.Crit Rev Oral Biol Med. 1997; 8: 291-305
- Epidemiology of orofacial pain: prevalence, incidence, and risk factors.in: Sessle B.J. Lavigne G.J. Lund J.P. Orofacial pain: from basic science to clinical management. 2nd edition. Quintessence Publishing, Chicago2008: 13-18
- Age peaks of different RDC/TMD diagnoses in a patient population.J Dent. 2010; 38: 392-399
- Diagnostic criteria for temporomandibular disorders (DC/TMD) for clinical and research applications: recommendations of the International RDC/TMD consortium network∗ and orofacial pain special interest groupdagger.J Oral Facial Pain Headache. 2014; 28: 6-27
- Orofacial pain: guidelines for assessment, diagnosis and management.6th edition. Quintessence Publishing Co, Inc, Hanover Park, IL2018: 143-207
- Headache classification committee of the international headache society (IHS) the international classification of headache disorders, 3rd edition.Cephalalgia. 2018; 38: 1-211
- International classification of orofacial pain, 1st edition (ICOP).Cephalalgia. 2020; 40: 129-221
- The prevalence of comorbid symptoms of central sensitization syndrome among three different groups of temporomandibular disorder patients.Pain Pract. 2013; 13: 604-613
- Myalgia, myofascial pain, tension-type headaches, and fibromyalgia.in: Sharav Y. Benoliel R. Orofacial pain and headache. 2nd edition. Quintessence Publishing Co, Inc., Chicago2015: 195-256
- The pathogenesis of muscle pain.Curr Pain Headache Rep. 2003; 7: 419-425
- Painful temporomandibular disorder: decade of discovery from OPPERA studies.J Dent Res. 2016; 95: 1084-1092
- Myofascial pain in temporomandibular disorders: Updates on etiopathogenesis and management.J Bodyw Mov Ther. 2021; 28: 104-113
- Cyclobenzaprine for the treatment of myofascial pain in adults.Cochrane Database Syst Rev. 2009; : CD006830
- Tricyclic analogs cyclobenzaprine, amitriptyline and cyproheptadine inhibit the spinal reflex transmission through 5-HT2 receptors.Eur J Pharmacol. 2003; 458: 91-99
- Special screening resources: strategies to identify substance use disorders, including opioid misuse and abuse.Dental Clin. 2020; 64: 513-524
- Systematic review and meta-analysis of randomized controlled trials evaluating intraoral orthopedic appliances for temporomandibular disorders.J Orofac Pain. 2010; 24: 237-254
- Effectiveness of occlusal splint therapy in the management of temporomandibular disorders: network meta-analysis of randomized controlled trials.Int J Oral Maxillofac Surg. 2020; 49: 1042-1056
- Pain catastrophizing and pain persistence in temporomandibular disorder patients.J Oral Facial Pain Headache. 2018; 32: 309-320
- Psychological therapies for the management of chronic pain (excluding headache) in adults.Cochrane Database Syst Rev. 2020; 8: CD007407
- Trigger point injections: a systematic, narrative review of the current literature.SN Compr Clin Med. 2020; 2: 746-752
- The superiority of water-diluted 0.25% to neat 1% lidocaine for trigger-point injections in myofascial pain syndrome: a prospective, randomized, double-blinded trial.Anesth Analg. 2000; 91: 408-409
- Myofascial pain syndrome treatments.Phys Med Rehabil Clin N Am. 2014; 25: 357-374
- Effectiveness, safety, and predictors of response to botulinum toxin type a in refractory masticatory myalgia: a retrospective study.J Oral Maxillofac Surg. 2017; 75: 2307-2315
- Cochrane systematic review and meta-analysis of botulinum toxin for the prevention of migraine.BMJ Open. 2019; 9: e027953
Article info
Publication history
Published online: October 26, 2022
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
